A fatty particle can clog arteries just as surely as cholesterol but often goes undetected, striking seemingly healthy people unaware of the danger. Though tests are widely available, they aren’t ...

Giant cell arteritis is a disease of the blood vessels, usually in the head/scalp and neck. Giant cell arteritis (GCA), or temporal arteritis, is an inflammatory disease affecting the large blood ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

CALI, Colombia—They see themselves as the cowboys of the drug trade, highly experienced crews that ferry narcotics on small boats across the open seas, running on a mix of bravado, skill and dreams of ...

The U.S. has revealed price reductions for the second round of prescription drugs negotiated by the Centers for Medicare & Medicaid Services (CMS) through the Inflation Reduction Act (IRA). Headlining ...

Late on Tuesday, the Trump administration announced price reductions for 15 drugs covered by the Medicare Part D program following negotiations with major drugmakers. The federal government says the ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy. The price cuts come through the Medicare ...

Popular weight loss drugs like Wegovy and Zepbound will soon cost Americans less under a new deal announced by President Donald Trump on Thursday. Agreements with drugmakers Novo Nordisk and Eli Lilly ...

President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications ...